Primrose Bio is a biotechnology company that focuses on discovery, development, and manufacturing of new molecules.
Primrose Bio has raised $2.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2026.
Primrose Bio's investors include National Science Foundation, 1315 Capital, Agent Capital, Signet Healthcare Partners, Ligand Pharmaceuticals.
Primrose Bio is headquartered in San Diego, United States.
Primrose Bio is a biotechnology company that focuses on discovery, development, and manufacturing of new molecules.
Primrose Bio is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Primrose Bio — Funding & Investors." VCBacked, September 22, 2026, https://www.vcbacked.co/company/primrose-bio. Accessed October 29, 2026.
VCBacked. (2026). Primrose Bio — Funding & Investors. Retrieved October 29, 2026, from https://www.vcbacked.co/company/primrose-bio
{{cite web |title=Primrose Bio — Funding & Investors |url=https://www.vcbacked.co/company/primrose-bio |website=VCBacked |access-date=October 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated